No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Clinical Trials, Phase II as Topic
-
Humans
-
Melanoma / drug therapy*
-
Recombinant Proteins / therapeutic use
-
Remission Induction
-
Tumor Necrosis Factor-alpha / therapeutic use*
Substances
-
Recombinant Proteins
-
Tumor Necrosis Factor-alpha